Executive Director of CMC, Hengrui Medicine Co., Ltd.
Dr. Yimin Hu graduated from Peking University with a Bachelor Degree in Chemistry in 2001. He then continued his PhD study in organic chemistry with Prof. Barry Trost at Stanford University, focusing on natural product synthesis and transition metal catalysis. After his graduation in 2007, he spent two years at Harvard University, as a Postdoc Fellow with Prof. Yoshito Kishi. In 2009, he came back to China and started his industry career as the Scientist of Medicinal Chemistry at GSK China R&D Center, followed by the Senior/Principal Scientist at Roche Innovation Center Shanghai. In 2017, Dr. Yimin Hu joined Jiangsu Hengrui Medicine Co., Ltd, and is currently the Head of Suzhou Suncadia Institute for Drug Development, leading Suzhou small molecule R&D platform.